Global Molecular Imager Market Research Report 2022

Due to the COVID-19 pandemic, the global Molecular Imager market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Molecular Imager market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Molecular Imager landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Nuclear Medicine accounting for % of the Molecular Imager global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Molecular Imager include 10xgenomics, Herolab GmbH Laborgeräte, Bio-Rad, Herolab GmbH, UVP, Vilber GmbH, Azure Biosystems, GE Healthcare Life Sciences and Gel Company. etc. In terms of revenue, the global 3 largest players have a % market share of Molecular Imager in 2021.
This report focuses on Molecular Imager volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Molecular Imager market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Molecular Imager Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Nuclear Medicine
PET/CT
Pet Radiation Pharmacy
Segment by Application
Oncology
Cardiovascular Diseases
Neurology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
10xgenomics
Herolab GmbH Laborgeräte
Bio-Rad
Herolab GmbH
UVP
Vilber GmbH
Azure Biosystems
GE Healthcare Life Sciences
Gel Company

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-20908117

11-May-2022

87
License